These findings suggest that targeting circ-002136 or the miR-19a-3p/RAB1A pathway could potentially inhibit HCC progression, offering novel insights into HCC development and identifying potential therapeutic targets [207]. The gene discussed is RAB1A; the disease is hepatocellular carcinoma.